Updated IAS-USA Antiretroviral Therapy Guidelines 2018

Rapid start of integrase inhibitor–based regimens is the theme of the updated guidelines.

Sponsoring Organization: International Antiviral Society–USA

Target Audience: HIV, infectious disease, and primary care clinicians caring for HIV-infected persons; public health experts

Background and Objective: Annual update of the adult antiretroviral therapy (ART) guidelines from a panel of experts, with ratings based on strength of scientific data that have been published, presented, or both

Key Points

ART is recommended for essentially all HIV-infected persons across the CD4-count spectrum.
Rapid initiation of ART after diagnosis is recommended despite requiring enhanced staffing and services. The regimen should be selected carefully depending on the circumstances.
Use of an integrase inhibitor–based regimen with two nucleoside reverse trans…

Reviewing Author

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Keith Henry, MD

Disclosures

Consultant/Advisory BoardViiV Advisory Board

Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes

Updated IAS-USA Antiretroviral Therapy Guidelines 2018

Topics

Reviewing Author